EMA is recommending that patients stop using Picato (ingenol mebutate), a gel for treating the skin condition actinic keratosis, while it continues its review of the medicine’s safety.
EMA’s safety committee (PRAC) has confirmed its recommendation to limit the use of high-strength creams containing 100 micrograms/gram (0.01%) of estradiol to a single treatment period of up to 4‑weeks. This follows a re-examination of its recommendation of October 2019 which was requested by one of the companies that market high-strength estradiol cream.
The RITMOCORE consortium – four hospitals and hospital foundations in Spain and the UK – invites interested bidders to submit offers to their public procurement of innovative solutions (PPI). This PPI aims to deploy innovative and more efficient service provisioning for patients with bradycardias and implantable pacemakers. The care model is based on personalized arrhythmia treatment, remote monitoring, coordinated care and patient activation. Deadline for submitting offers is 16 March 2020.
Yesterday, Member States unanimously supported a Commission proposal consolidating the protective measures in relation to outbreaks of highly pathogenic avian influenza (HPAI) of subtype H5N8 in the four affected Member States (Poland, Slovakia, Hungary and Romania).
European Commission President Ursula von der Leyen met with Taoiseach of Ireland Leo Varadkar in Dublin on 15 January. They discussed among others Brexit, the European Green Deal and the negotiations on the EU’s future budget.